March 13th 2025
The study found that just 20% of trials submitted to both the FDA and European Medicines Agency had matching evidence.
February 27th 2025
Data on Delandistrogene Moxeparvovec Can Inform Future Gene Therapies
Despite Risk, Patients With SCD Hopeful About Gene Therapies